Genomind
Business Services · Pennsylvania, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
2200 Renaissance Blvd Ste 100, King of P...Phone Number
(877) 895-8658Website
www.genomind.comRevenue
$29.5 MillionIndustry
About Genomind
Genomind is a pharmacogenetic testing laboratory specializing in personalized medicine in the field of psychiatry, comprised of innovative researchers and expert leaders in psychiatry and neurology. Genomind is committed to discovery of the underlying causes of neuropsychiatric disorders and supports the development of personalized medicine that improves patients' lives. Genomind was founded by Ronald I. Dozoretz, MD, a psychiatrist who has devoted his career to improving mental health. Jay Lombard, DO, a neurologist and co-founder of Genomind, is a critically acclaimed author and nationally recognized thought leader in neuropsychiatry practice and research.Explore more
Genomind Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Genomind
Compare insights from companies similar to Genomind, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Genomind Tech Stack
A closer look at the technologies used by Genomind
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Genomind
Sign Up For FreeTo access detailed company insights
Genomind is a pharmacogenetic testing laboratory specializing in personalized medicine in the field of psychiatry, comprised of innovative researchers and expert leaders in psychiatry and neurology. Genomind is committed to discovery of the underlying causes of neuropsychiatric disorders and supports the development of personalized medicine that im... Read More
